ENDRA Life Sciences (NASDAQ:NDRA – Get Free Report) is scheduled to be posting its quarterly earnings results after the market closes on Tuesday, May 14th.
ENDRA Life Sciences (NASDAQ:NDRA – Get Free Report) last issued its quarterly earnings results on Thursday, March 28th. The company reported ($0.17) earnings per share for the quarter.
ENDRA Life Sciences Stock Down 6.4 %
NDRA opened at $0.30 on Wednesday. The company has a market cap of $3.33 million, a P/E ratio of -0.16 and a beta of 1.13. The firm’s 50-day moving average price is $0.63 and its 200-day moving average price is $1.02. ENDRA Life Sciences has a 52-week low of $0.22 and a 52-week high of $2.79.
ENDRA Life Sciences Company Profile
ENDRA Life Sciences Inc develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.
See Also
- Five stocks we like better than ENDRA Life Sciences
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- How to Read an Earnings Report | Step by Step Guide with Tips
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Datadog: In the Doghouse or Pullback to the Buyzone?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Celsius Stock’s Post-Earnings Morning Dip, Better than Coffee
Receive News & Ratings for ENDRA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ENDRA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
